Chemicals · NSE: BALAMINES
Balaji Amines
Q2 FY27 earnings and concall highlights
Q2 FY27 earnings call · Guided by management
Call held 4 Nov 2026 · Read the filing on NSEFiling
- M.Cap
- ₹6,093Cr
- P/E
- 25.6×
- 1Y return
- +53.04%
- From 52W high
- −28.5%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 468 | 341 | +37.3% | 456 | +2.6% |
| EBITDA | 102 | 60 | +69.8% | 116 | -12.3% |
| EBITDA margin | 21.7% | 17.6% | +416 bps | 25.4% | -369 bps |
| PBTProfit before tax | 89 | 52 | +73.0% | 106 | -15.9% |
| Net profit | 67 | 35 | +94.6% | 75 | -10.2% |
| EPS (₹) | 20.76 | 10.67 | +94.6% | 23.13 | -10.2% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
More figures from the call
“so export and domestic together, we should minimum do 50% to 60% capacity in the next year.”
“So we should be in a position to produce a minimum 1,000 to 1,200 tons every month, minimum.”
“With this improved process and the expanded capacity has increased to 1,440 tons per month.”
“Earlier, we were running about 30%, 40%. Now I think it's almost more than 50% capacity utilization is going on.”
“No, Unit-3 was operating almost 80% capacity.”
“15%, 20% its utilization is there.”
In short
- 01Q2 FY27 consolidated revenue was Rs 472 crore against Rs 348 crore a year earlier; PAT was Rs 67 crore.
- 02Management aims for Rs 3,500 to 4,000 crore top line by '28-'29 as all expansions come on stream.
- 03Acetonitrile capacity rose to 1,440 tons a month; at least 1,000 to 1,200 tons a month expected from December.
- 04DME utilisation next year seen above 90% if LPG blending is approved, else at least 50% to 60%.
- 05Unit-1 brownfield products expected from January; Unit-2 from January, possibly slipping to February or March.
- 06All expansions and capital investment to close by end of FY27; plants seen at up to 80-90% utilisation.
- 07EDA anti-dumping duty was not implemented; company plans a writ petition in the High Court.
- 08Consolidated debt was Rs 161.15 crore; standalone company has zero debt.
Capex
EDA: Plant runs 20 days and is modified 10 days to stay in the market
D Ram Reddy · Q&A · p. 8
EDA: Plant runs 20 days and is modified 10 days to stay in the market
“We are running for the 20 days and doing the modifications 10 days. Like that, we are doing because we don't want to lose the market.”
Balaji Specialty Chemicals: Unit-1 EDA derivatives brownfield project expected commissioned towards end of FY27
D Ram Reddy · p. 5
Balaji Specialty Chemicals: Unit-1 EDA derivatives brownfield project expected commissioned towards end of FY27
“In Unit-1, the brownfield expansion project involving EDA-based derivatives, including DETA, TETA, Piperazine, AEEA, and AEP is progressing and is expected to be commissioned towards the end of FY27.”
Balaji Specialty Chemicals: Unit-2 greenfield cyanide and EDTA project targeted for commissioning in Q4 FY27
D Ram Reddy · p. 5
Balaji Specialty Chemicals: Unit-2 greenfield cyanide and EDTA project targeted for commissioning in Q4 FY27
“At Unit-2, the greenfield expansion project at MIDC, Chincholi for the manufacture of hydrogen cyanide, sodium cyanide, EDTA and EDTA-2Na is progressing with equipment erection and installation activities. The project is targeted for commissioning in Q4 FY27.”
EDA: Brownfield modifications to complete and new products by end of this financial year
D Ram Reddy · Q&A · p. 8
EDA: Brownfield modifications to complete and new products by end of this financial year
“By end of this financial year, we will see the new products. We'll be completing the brownfield modifications.”
All plants to start commercial production by end of this year; full capacity by 2028-29
D Ram Reddy · Q&A · p. 10
All plants to start commercial production by end of this year; full capacity by 2028-29
“Like the entire capacities will come by the 2028, '29. As I said, by end of this current financial year, all these plants will commence the commercial production.”
Capacity
Carbonates: Carbonate capacity ran at 20-30% vs 80-90% projected
D Ram Reddy · Q&A · p. 7
Carbonates: Carbonate capacity ran at 20-30% vs 80-90% projected
“As this existing capacity itself, we were lagging to 30%, 20% as against of the 80%, 90% of the projections.”
EDA: EDA plant working at about 50% to 60% capacity as prices improved
D Ram Reddy · Q&A · p. 7
EDA: EDA plant working at about 50% to 60% capacity as prices improved
“There is actually price have been improved on the EDA. We are working at almost 50% to 60% capacity.”
Acetonitrile: Acetonitrile to reach full 1,440 tons a month in coming 2 to 3 weeks
D Ram Reddy · Q&A · p. 9
Acetonitrile: Acetonitrile to reach full 1,440 tons a month in coming 2 to 3 weeks
“Maybe in the coming 2, 3 weeks, it will go in full swing with the full capacity of 1,440 metric tons per month of Acetonitrile.”
EDA: Old plant and expanded plant both to run as per market conditions
D Ram Reddy · Q&A · p. 8
EDA: Old plant and expanded plant both to run as per market conditions
“And also the old plant will be running as per the market conditions, both the plants will be running.”
Segments
EDA: EDA could possibly run at full capacity from next 1 or 2 quarters
D Ram Reddy · Q&A · p. 8
EDA: EDA could possibly run at full capacity from next 1 or 2 quarters
“But now for a short period, there is an opportunity with the price improvements. So there's a possibility that from the next 1 or 2 quarters, the possibility of running in full capacity.”
Acetonitrile: Acetonitrile focus now on stabilising operations, customers and utilisation
D Ram Reddy · p. 5
Acetonitrile: Acetonitrile focus now on stabilising operations, customers and utilisation
“Our focus will now be on stabilizing operations, developing the customer base and progressively improving utilization of this expanded capacity.”
DME: Aerosol named as a key DME opportunity; customer and distribution network being built
D Ram Reddy · p. 5
DME: Aerosol named as a key DME opportunity; customer and distribution network being built
“The Aerosol segment represents an important opportunity for DME and our efforts are directed towards establishing a sustainable customer and distribution network.”
Demand
Q2 volumes 24,491 tons vs 26,165 tons a year earlier, down about 6%
D Ram Reddy · p. 4
Q2 volumes 24,491 tons vs 26,165 tons a year earlier, down about 6%
“Consolidated sales volumes for Q2 FY27 stood at 24,491 metric tons compared to 26,165 metric tons in Q2 FY26, representing a moderation of approximately 6%.”
Q2 volumes up about 13.5% from Q1 FY27
D Ram Reddy · p. 4
Q2 volumes up about 13.5% from Q1 FY27
“However, on a sequential basis, volumes improved by approximately 13.5% compared to Q1 FY27.”
DMC / propylene carbonate: Battery customer asking 500 to 1,000 tons of carbonates; supply from next month
D Ram Reddy · Q&A · p. 7
DMC / propylene carbonate: Battery customer asking 500 to 1,000 tons of carbonates; supply from next month
“And this quarter, they are asking almost 500 to 1,000 tons of the both the carbonates like dimethyl carbonate and propylene carbonate. Probably by next month onwards, we should be in a position to deliver these 500 to 1000 tons.”
DME: About 7 to 8 DME ISO tanks exported, with repeat aerosol orders
D Ram Reddy · Q&A · p. 8
DME: About 7 to 8 DME ISO tanks exported, with repeat aerosol orders
“So almost 7 to 8 tanks have been exported. And it is on a repeated basis, we are getting the orders for the exports in the ISO tank for the Aerosol application.”
DME: Major aerosol makers trialling DME in cylinders
D Ram Reddy · Q&A · p. 9
DME: Major aerosol makers trialling DME in cylinders
“In some of the major aerosol manufacturers have taken in the cylinders. They are doing their trials.”
Margins and costs
Q2 EBITDA Rs 106 crore, up about 58%; margin 22% vs 19%
D Ram Reddy · p. 3
Q2 EBITDA Rs 106 crore, up about 58%; margin 22% vs 19%
“Consolidated EBITDA for the quarter stood at INR106 crores compared to INR67 crores in the corresponding quarter last year, reflecting a growth of approximately 58% EBITDA margin stood at 22% compared to 19% in Q2 FY26.”
DMF: DMF prices now above INR110-115
D Ram Reddy · Q&A · p. 7
DMF: DMF prices now above INR110-115
“Present prices are going on more than INR110, INR115 of the basic for the DMF.”
DME: DME price now INR90 to INR100; expected lower if methanol falls below INR80
D Ram Reddy · Q&A · p. 9
DME: DME price now INR90 to INR100; expected lower if methanol falls below INR80
“So the reason it is somewhere in the INR90 to INR100 is the current price. We expect that it should go down the moment methanol goes down to below INR80 level, which will be much better competitive when compared to the LPG.”
Acetonitrile: Acetonitrile price around INR230 to INR240, tied to raw material prices
D Ram Reddy · Q&A · p. 9
Acetonitrile: Acetonitrile price around INR230 to INR240, tied to raw material prices
“The current prices around INR230, INR240 level is going on.”
In normal times prices rise about 7% to 8% a year
D Ram Reddy · Q&A · p. 11
In normal times prices rise about 7% to 8% a year
“see year-on-year, there should be 7% to 8% increase. This is my earlier graphics what we have seen.”
Debt and working capital
Standalone company keeps zero debt
D Ram Reddy · p. 6
Standalone company keeps zero debt
“On a stand-alone basis Balaji Amines continues to maintain a zero debt position.”
Consolidated net worth corrected to Rs 2,083.02 crore
D Ram Reddy · p. 5
Consolidated net worth corrected to Rs 2,083.02 crore
“please note the Consolidated Net worth should be read as Rs. 2,083.02”
Consolidated debt Rs 161.15 crore; cash Rs 52.62 crore
D Ram Reddy · p. 6
Consolidated debt Rs 161.15 crore; cash Rs 52.62 crore
“Consolidated debt stood at INR161.15 crores, while cash and cash equivalents stood at INR52.62 crores.”
H1 FY27 operating cash flow Rs 54.46 crore
D Ram Reddy · p. 6
H1 FY27 operating cash flow Rs 54.46 crore
“During H1 FY27, cash flow from operating activities stood at INR54.46 crores.”
Acquisitions and new business
Specialty chemicals: N-Methyl Morpholine (NMM) is next product; commercialization aimed for FY27
D Ram Reddy · p. 5
Specialty chemicals: N-Methyl Morpholine (NMM) is next product; commercialization aimed for FY27
“Our next product in the pipeline is N-Methyl Morpholine or NMM, which will further strengthen our specialty chemicals portfolio. The project is progressing, and we remain focused on its commercialization during FY27.”
One-offs
Balaji Specialty Chemicals: Balaji Specialty Chemicals reported some profit this quarter
D Ram Reddy · Q&A · p. 11
Balaji Specialty Chemicals: Balaji Specialty Chemicals reported some profit this quarter
“This quarter also, Balaji Specialty Chemicals has shown some profit in the quarter.”
Risks
Management names raw material prices, global demand and geopolitics as external factors
D Ram Reddy · p. 6
Management names raw material prices, global demand and geopolitics as external factors
“We remain mindful of external factors, including raw material prices, global demand conditions and geopolitical developments.”
EDA: EDA anti-dumping duty recommended by Commerce but not implemented by Finance Ministry
D Ram Reddy · Q&A · p. 7
EDA: EDA anti-dumping duty recommended by Commerce but not implemented by Finance Ministry
“And the antidumping did not take place because the Commerce Ministry has recommended, but Finance Ministry did not implement that.”
EDA: Company may file High Court writ petition on anti-dumping within 1 month
D Ram Reddy · Q&A · p. 8
EDA: Company may file High Court writ petition on anti-dumping within 1 month
“So we are approaching the court like other companies also approached, we are also approaching the High Court. Probably in the coming 1 month, we may file this writ petition.”
Intermediaries raise raw material prices on news events
D Ram Reddy · Q&A · p. 11
Intermediaries raise raw material prices on news events
“Simply today, somebody says that there's a bomb blast, immediately, they will increase the prices without looking into their cost price, they will double the prices.”
EDA: Finance Ministry did not implement recommended EDA anti-dumping duty; writ petition prepared
D Ram Reddy · Q&A · p. 8
EDA: Finance Ministry did not implement recommended EDA anti-dumping duty; writ petition prepared
“has recommended, but Finance Ministry did not implement that. And now we have prepared for a writ petition for implementing this against the Finance Department.”
Other
Q2 FY27 consolidated revenue Rs 472 crore vs Rs 348 crore in Q2 FY26
D Ram Reddy · p. 3
Q2 FY27 consolidated revenue Rs 472 crore vs Rs 348 crore in Q2 FY26
“Coming to our consolidated financial performance for Q2 FY27, revenue stood at INR472 crores compared to INR348 crores in Q2 FY26”
Q2 PAT Rs 67 crore vs Rs 37 crore, up about 82%
D Ram Reddy · p. 3
Q2 PAT Rs 67 crore vs Rs 37 crore, up about 82%
“Profit after tax for the quarter stood at INR67 crores against INR37 crores in Q2 FY26, registering a growth of approximately 82%.”
H1 FY27 revenue Rs 933 crore vs Rs 715 crore, up about 31%
D Ram Reddy · p. 4
H1 FY27 revenue Rs 933 crore vs Rs 715 crore, up about 31%
“consolidated revenue for H1 FY27 stood at INR933 crores compared to INR715 crores in H1 FY26, registering a growth of approximately 31%.”
H1 FY27 PAT Rs 146 crore vs Rs 74 crore, up about 98%
D Ram Reddy · p. 4
H1 FY27 PAT Rs 146 crore vs Rs 74 crore, up about 98%
“Consolidated PAT for H1 FY27 stood at INR146 crores compared to INR74 crores in H1 FY26, registering a growth of approximately 98%.”
DME: PESO Nagpur approved DME road tanker valves
D Ram Reddy · p. 5
DME: PESO Nagpur approved DME road tanker valves
“It is with great pleasure to share the news of Dimethyl Ether Road Tanker valves approval from the PESO Nagpur office after a thorough testing process.”
Sources
- Earnings call transcript, Q2 FY27 Filed 9 Nov 2026 · 13 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

